In the next issue of Pharma Technology Focus, we delve into the biggest topics set to influence the global market in 2020 and beyond. But first, we take a look back at the development of breast cancer treatment following the news that the number of cancer deaths has declined by almost 50% since the 1980s.
Looking forward, we investigate why access to PrEp drugs in England is restricted to patients in the NHS Impact trial despite the proven efficacy of the treatment, ask if Big Pharma can be taxed into putting patients before profits, and find out how companies are addressing the burden of endometriosis.
Plus, we track the rise of fake medications in Africa, examine a CAR-T therapy that protects non-diseased T cells, explore how 2019 Nobel Prize-winning research into how oxygen levels affect cellular metabolism and physiological function will change drug discovery, and finally, we look to the East to find out what is next for China’s surging market.
Editor | Eloise McLennan
Group Editor | Susanne Hauner
Commissioning Editor | Daniel Garrun
Writers | Allie Nawrat, Abi Millar, Chris Lo
Magazine Designer | Marzia Del Gaone
Graphic Designers | Anett Arc, Ashley McPherson, Tyrrell Lowe, Noemi Balint, Petra Konyi-Kiss, Maria Gimenez, Martina Labaiova, Filipe Costa
Lead Designer | John Hammond
Digital Publishing Director | Duncan West
Sales Manager | Nimai Amin
+44 (0) 207 936 6453
For media partnership enquiries please contact our publishing assistant: Sophie Hoare
Pharma Technology focus is powered by h5mag
read past issues of pharma technology focus HERE
Pharma Technology Focus is a product of Net Resources International. Copyright 2019 Net Resources International, a trading division of Kable Intelligence Limited. Registered office John Carpenter House, John Carpenter Street, London, EC4Y 0AN, UK. Company registration number 03171601. All rights reserved. No part of this publication may be reproduced in any form or by any means, electronic, photocopying or otherwise, without prior permission of the publisher and copyright owner. While every effort has been made to ensure the accuracy of this publication, the publisher accepts no responsibility for errors or omissions. The products and services advertised are those of individual authors and are not necessarily endorsed by or connected with the publisher. The opinions expressed in the articles within this publication are those of individual authors and not necessarily those of the publisher.